IBDEI04U ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6194,1,3,0)
 ;;=3^Exotropia,Alternating
 ;;^UTILITY(U,$J,358.3,6194,1,4,0)
 ;;=4^378.15
 ;;^UTILITY(U,$J,358.3,6194,2)
 ;;=^265415
 ;;^UTILITY(U,$J,358.3,6195,0)
 ;;=378.11^^36^399^11
 ;;^UTILITY(U,$J,358.3,6195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6195,1,3,0)
 ;;=3^Exotropia,Monocular
 ;;^UTILITY(U,$J,358.3,6195,1,4,0)
 ;;=4^378.11
 ;;^UTILITY(U,$J,358.3,6195,2)
 ;;=^265413
 ;;^UTILITY(U,$J,358.3,6196,0)
 ;;=378.51^^36^399^17
 ;;^UTILITY(U,$J,358.3,6196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6196,1,3,0)
 ;;=3^Nerve Palsy,Partial Third
 ;;^UTILITY(U,$J,358.3,6196,1,4,0)
 ;;=4^378.51
 ;;^UTILITY(U,$J,358.3,6196,2)
 ;;=^118774
 ;;^UTILITY(U,$J,358.3,6197,0)
 ;;=378.54^^36^399^18
 ;;^UTILITY(U,$J,358.3,6197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6197,1,3,0)
 ;;=3^Nerve Palsy,Sixth
 ;;^UTILITY(U,$J,358.3,6197,1,4,0)
 ;;=4^378.54
 ;;^UTILITY(U,$J,358.3,6197,2)
 ;;=^265334
 ;;^UTILITY(U,$J,358.3,6198,0)
 ;;=378.53^^36^399^16
 ;;^UTILITY(U,$J,358.3,6198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6198,1,3,0)
 ;;=3^Nerve Palsy,Fourth
 ;;^UTILITY(U,$J,358.3,6198,1,4,0)
 ;;=4^378.53
 ;;^UTILITY(U,$J,358.3,6198,2)
 ;;=^265326
 ;;^UTILITY(U,$J,358.3,6199,0)
 ;;=360.01^^36^400^50
 ;;^UTILITY(U,$J,358.3,6199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6199,1,3,0)
 ;;=3^Endophalmitis
 ;;^UTILITY(U,$J,358.3,6199,1,4,0)
 ;;=4^360.01
 ;;^UTILITY(U,$J,358.3,6199,2)
 ;;=Endophalmitis^268545
 ;;^UTILITY(U,$J,358.3,6200,0)
 ;;=V08.^^36^400^53
 ;;^UTILITY(U,$J,358.3,6200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6200,1,3,0)
 ;;=3^HIV Status
 ;;^UTILITY(U,$J,358.3,6200,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,6200,2)
 ;;=HIV Status^303392
 ;;^UTILITY(U,$J,358.3,6201,0)
 ;;=130.2^^36^400^87
 ;;^UTILITY(U,$J,358.3,6201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6201,1,3,0)
 ;;=3^Toxoplasmosis Retinitis
 ;;^UTILITY(U,$J,358.3,6201,1,4,0)
 ;;=4^130.2
 ;;^UTILITY(U,$J,358.3,6201,2)
 ;;=Toxoplasmosis Retinitis^266947
 ;;^UTILITY(U,$J,358.3,6202,0)
 ;;=128.0^^36^400^86
 ;;^UTILITY(U,$J,358.3,6202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6202,1,3,0)
 ;;=3^Toxocariasis
 ;;^UTILITY(U,$J,358.3,6202,1,4,0)
 ;;=4^128.0
 ;;^UTILITY(U,$J,358.3,6202,2)
 ;;=Toxocariasis^120683
 ;;^UTILITY(U,$J,358.3,6203,0)
 ;;=054.42^^36^400^48
 ;;^UTILITY(U,$J,358.3,6203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6203,1,3,0)
 ;;=3^Dendritic Keratitis
 ;;^UTILITY(U,$J,358.3,6203,1,4,0)
 ;;=4^054.42
 ;;^UTILITY(U,$J,358.3,6203,2)
 ;;=Dendritic Keratitis^66763
 ;;^UTILITY(U,$J,358.3,6204,0)
 ;;=370.01^^36^400^65
 ;;^UTILITY(U,$J,358.3,6204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6204,1,3,0)
 ;;=3^Marginal Corneal Ulcer
 ;;^UTILITY(U,$J,358.3,6204,1,4,0)
 ;;=4^370.01
 ;;^UTILITY(U,$J,358.3,6204,2)
 ;;=Marginal Corneal Ulcer^268908
 ;;^UTILITY(U,$J,358.3,6205,0)
 ;;=375.30^^36^400^47
 ;;^UTILITY(U,$J,358.3,6205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6205,1,3,0)
 ;;=3^Dacrocystitis
 ;;^UTILITY(U,$J,358.3,6205,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,6205,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,6206,0)
 ;;=376.01^^36^400^69
 ;;^UTILITY(U,$J,358.3,6206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6206,1,3,0)
 ;;=3^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,6206,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,6206,2)
 ;;=Orbital Cellulitis^259068
 ;;^UTILITY(U,$J,358.3,6207,0)
 ;;=682.0^^36^400^6
 ;;^UTILITY(U,$J,358.3,6207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6207,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,6207,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,6207,2)
 ;;=Cellulitis of Face^271888
 ;;^UTILITY(U,$J,358.3,6208,0)
 ;;=473.9^^36^400^84
 ;;^UTILITY(U,$J,358.3,6208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6208,1,3,0)
 ;;=3^Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,6208,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,6208,2)
 ;;=Sinusitis^123985
 ;;^UTILITY(U,$J,358.3,6209,0)
 ;;=017.30^^36^400^90
 ;;^UTILITY(U,$J,358.3,6209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6209,1,3,0)
 ;;=3^Tuberculosis,Eye
 ;;^UTILITY(U,$J,358.3,6209,1,4,0)
 ;;=4^017.30
 ;;^UTILITY(U,$J,358.3,6209,2)
 ;;=^122722
 ;;^UTILITY(U,$J,358.3,6210,0)
 ;;=076.9^^36^400^88
 ;;^UTILITY(U,$J,358.3,6210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6210,1,3,0)
 ;;=3^Trachoma,Unspec
 ;;^UTILITY(U,$J,358.3,6210,1,4,0)
 ;;=4^076.9
 ;;^UTILITY(U,$J,358.3,6210,2)
 ;;=^120805
 ;;^UTILITY(U,$J,358.3,6211,0)
 ;;=077.0^^36^400^31
 ;;^UTILITY(U,$J,358.3,6211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6211,1,3,0)
 ;;=3^Conjunctivitis,Inclusion
 ;;^UTILITY(U,$J,358.3,6211,1,4,0)
 ;;=4^077.0
 ;;^UTILITY(U,$J,358.3,6211,2)
 ;;=^27600
 ;;^UTILITY(U,$J,358.3,6212,0)
 ;;=077.1^^36^400^61
 ;;^UTILITY(U,$J,358.3,6212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6212,1,3,0)
 ;;=3^Keratoconjunctivitis,Epidemic EKC
 ;;^UTILITY(U,$J,358.3,6212,1,4,0)
 ;;=4^077.1
 ;;^UTILITY(U,$J,358.3,6212,2)
 ;;=^41251
 ;;^UTILITY(U,$J,358.3,6213,0)
 ;;=077.8^^36^400^37
 ;;^UTILITY(U,$J,358.3,6213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6213,1,3,0)
 ;;=3^Conjunctivitis,Viral,Oth
 ;;^UTILITY(U,$J,358.3,6213,1,4,0)
 ;;=4^077.8
 ;;^UTILITY(U,$J,358.3,6213,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,6214,0)
 ;;=078.5^^36^400^46
 ;;^UTILITY(U,$J,358.3,6214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6214,1,3,0)
 ;;=3^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,6214,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,6214,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,6215,0)
 ;;=090.3^^36^400^59
 ;;^UTILITY(U,$J,358.3,6215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6215,1,3,0)
 ;;=3^Keratitis,Interstitial,Syphilitic
 ;;^UTILITY(U,$J,358.3,6215,1,4,0)
 ;;=4^090.3
 ;;^UTILITY(U,$J,358.3,6215,2)
 ;;=^266697
 ;;^UTILITY(U,$J,358.3,6216,0)
 ;;=091.50^^36^400^93
 ;;^UTILITY(U,$J,358.3,6216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6216,1,3,0)
 ;;=3^Uveitis Syphilitica,Unspec
 ;;^UTILITY(U,$J,358.3,6216,1,4,0)
 ;;=4^091.50
 ;;^UTILITY(U,$J,358.3,6216,2)
 ;;=^266715
 ;;^UTILITY(U,$J,358.3,6217,0)
 ;;=094.83^^36^400^83
 ;;^UTILITY(U,$J,358.3,6217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6217,1,3,0)
 ;;=3^Retinochoroiditis,Dissem,Syphilitic
 ;;^UTILITY(U,$J,358.3,6217,1,4,0)
 ;;=4^094.83
 ;;^UTILITY(U,$J,358.3,6217,2)
 ;;=^266752
 ;;^UTILITY(U,$J,358.3,6218,0)
 ;;=099.3^^36^400^82
 ;;^UTILITY(U,$J,358.3,6218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6218,1,3,0)
 ;;=3^Reiter's Disease
 ;;^UTILITY(U,$J,358.3,6218,1,4,0)
 ;;=4^099.3
 ;;^UTILITY(U,$J,358.3,6218,2)
 ;;=^104534
 ;;^UTILITY(U,$J,358.3,6219,0)
 ;;=112.89^^36^400^5
 ;;^UTILITY(U,$J,358.3,6219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6219,1,3,0)
 ;;=3^Candida,Oth
 ;;^UTILITY(U,$J,358.3,6219,1,4,0)
 ;;=4^112.89
 ;;^UTILITY(U,$J,358.3,6219,2)
 ;;=^87368
 ;;^UTILITY(U,$J,358.3,6220,0)
 ;;=136.1^^36^400^1
 ;;^UTILITY(U,$J,358.3,6220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6220,1,3,0)
 ;;=3^Behcet's Disease
 ;;^UTILITY(U,$J,358.3,6220,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,6220,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,6221,0)
 ;;=190.3^^36^400^11
 ;;^UTILITY(U,$J,358.3,6221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6221,1,3,0)
 ;;=3^Conjunctiva Malig Neopl
 ;;^UTILITY(U,$J,358.3,6221,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,6221,2)
 ;;=^267274
 ;;^UTILITY(U,$J,358.3,6222,0)
 ;;=198.89^^36^400^91
 ;;^UTILITY(U,$J,358.3,6222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6222,1,3,0)
 ;;=3^Uveal Metastasis
 ;;^UTILITY(U,$J,358.3,6222,1,4,0)
 ;;=4^198.89
 ;;^UTILITY(U,$J,358.3,6222,2)
 ;;=^267330
 ;;^UTILITY(U,$J,358.3,6223,0)
 ;;=202.80^^36^400^64
 ;;^UTILITY(U,$J,358.3,6223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6223,1,3,0)
 ;;=3^Lymphoma,Extranod/Solid Org,Unspec Site
 ;;^UTILITY(U,$J,358.3,6223,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,6223,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,6224,0)
 ;;=224.3^^36^400^12
 ;;^UTILITY(U,$J,358.3,6224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6224,1,3,0)
 ;;=3^Conjunctiva,Benign Neopl
 ;;^UTILITY(U,$J,358.3,6224,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,6224,2)
 ;;=^267673
 ;;^UTILITY(U,$J,358.3,6225,0)
 ;;=238.8^^36^400^68
 ;;^UTILITY(U,$J,358.3,6225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6225,1,3,0)
 ;;=3^Neopl,Uncert Behavior,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,6225,1,4,0)
 ;;=4^238.8
 ;;^UTILITY(U,$J,358.3,6225,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,6226,0)
 ;;=360.11^^36^400^92
 ;;^UTILITY(U,$J,358.3,6226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6226,1,3,0)
 ;;=3^Uveitis Sympathetic
 ;;^UTILITY(U,$J,358.3,6226,1,4,0)
 ;;=4^360.11
 ;;^UTILITY(U,$J,358.3,6226,2)
 ;;=^85809
 ;;^UTILITY(U,$J,358.3,6227,0)
 ;;=360.12^^36^400^74
 ;;^UTILITY(U,$J,358.3,6227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6227,1,3,0)
 ;;=3^Panuveitis
 ;;^UTILITY(U,$J,358.3,6227,1,4,0)
 ;;=4^360.12
 ;;^UTILITY(U,$J,358.3,6227,2)
 ;;=^89553
 ;;^UTILITY(U,$J,358.3,6228,0)
 ;;=360.13^^36^400^51
 ;;^UTILITY(U,$J,358.3,6228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6228,1,3,0)
 ;;=3^Endophthalmitis,Parasitic
 ;;^UTILITY(U,$J,358.3,6228,1,4,0)
 ;;=4^360.13
 ;;^UTILITY(U,$J,358.3,6228,2)
 ;;=^40618
 ;;^UTILITY(U,$J,358.3,6229,0)
 ;;=360.30^^36^400^54
 ;;^UTILITY(U,$J,358.3,6229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6229,1,3,0)
 ;;=3^Hypotony,Unspec
 ;;^UTILITY(U,$J,358.3,6229,1,4,0)
 ;;=4^360.30
 ;;^UTILITY(U,$J,358.3,6229,2)
 ;;=^268556
 ;;^UTILITY(U,$J,358.3,6230,0)
 ;;=363.00^^36^400^8
 ;;^UTILITY(U,$J,358.3,6230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6230,1,3,0)
 ;;=3^Chorioretinitis,Focal,Unspec
 ;;^UTILITY(U,$J,358.3,6230,1,4,0)
 ;;=4^363.00
 ;;^UTILITY(U,$J,358.3,6230,2)
 ;;=^268662
 ;;^UTILITY(U,$J,358.3,6231,0)
 ;;=363.10^^36^400^7
 ;;^UTILITY(U,$J,358.3,6231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6231,1,3,0)
 ;;=3^Chorioretinitis,Disseminated
 ;;^UTILITY(U,$J,358.3,6231,1,4,0)
 ;;=4^363.10
 ;;^UTILITY(U,$J,358.3,6231,2)
 ;;=^268672
 ;;^UTILITY(U,$J,358.3,6232,0)
 ;;=363.21^^36^400^75
